Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

18.191.254.51
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Musculoskeletal/Rheumatology
Rheumatology

Study highlights risk factors of vena cava syndrome in Behçet’s syndrome

Posted on

Potential risk factors of vena cava syndrome (VCS) in patients with Behçet’s syndrome (BS) include male, early-onset Behçet’s syndrome (BS), ESR >60 mm/hour, and pathergy reaction, according to a study.

In this case-control study data from 55 cases of patients with BS with VCS and 2 patients without VCS for each VCS case using risk-set-sampling was used to detect the risk factors of VCS and overall outcomes.

-Advertisement-
-Advertisement-

Male gender (OR 11.16, 95%CI 3.34-37.32), early-onset BS (<18 years) (OR 5.57, 95%CI 1.58-19.69), ESR >60 mm/hr (OR 3.83, 95%CI 1.02-12.23), and pathergy reaction (OR 5.10, 95%CI 2.11-12.32) were identified potential risk factors of VCS in BS patients with a multivariable logistic regression analysis.

Spectral computed tomography imaging was found to be valuable in detecting thrombosis in BS patients with inferior VCS.

Over a median 3.3 years follow-up, the estimated 1- and 5-year survival rates were 96.3% and 94.2%, respectively, and the estimated 1- and 5-year relapse-free rates were 93.9% and 78.0%, respectively.

Reference
Zhou J, Zhang D, Wang Z, et al. The clinical features, image findings and risk factors of vena cava syndrome in Behçet’s syndrome. Clin Exp Rheumatol. 2022;doi: 10.55563/clinexprheumatol/r6her6. Epub ahead of print. PMID: 35819814.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-